AZN - AstraZeneca beats top-line and bottom-line estimates; reaffirms FY24 outlook
2024-04-25 02:24:51 ET
More on AstraZeneca:
- AstraZeneca: What The Market's Missing
- What AstraZeneca Is Getting Through The Acquisition Of Fusion Pharmaceuticals
- 5 Reasons AstraZeneca Stock Can Rise In 2024
- Liquid biopsy firm Angle signs new commercial agreement with AstraZeneca